SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-21-000058
Filing Date
2021-08-13
Accepted
2021-08-12 17:48:51
Documents
7
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 7236
2 NEW RELEASE ex99_1.htm EX-99.1 59509
3 NEWS RELEASE DATED FEBRUARY 10, 2021 ex99_2.htm EX-99.2 7890
4 NEWS RELEASE DATED FEBRUARY 18, 2021 ex99_3.htm EX-99.3 8476
5 image00002.jpg GRAPHIC 4681
6 image00003.jpg GRAPHIC 4674
7 image00004.jpg GRAPHIC 2543
  Complete submission text file 0001085037-21-000058.txt   101193
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 211169027
SIC: 2836 Biological Products, (No Diagnostic Substances)